Pluss raises $1 million in funding

Published On 2015-11-28 06:44 GMT   |   Update On 2015-11-28 06:44 GMT
Advertisement
Another online healthcare start-up Pluss, which delivers medicine and healthcare products on-demand, has raised $1 million in pre-Series A funding. The investors are IDG Ventures India, m & s partners (Singapore) and Powerhouse Ventures (USA).

The healthcare venture plans to invest the amount in technology up gradation (which also includes the expansion of the team), promote its services in 5 cities, and pilot new projects.

Based out of Gurgaon, Pluss was incorporated in 2015 by Atit Jain, Madhulika Pandey and Tarun Lawadia.

The delivery executives addressed as 'Pluss Men', also deliver baby care, pet care, personal wellness and daily essential products.

The team, comprising licensed pharmacists and trained delivery executives, is equipped to handle medicine properly and make sure that they are delivered with utmost care.

Atit Jain, CEO of Pluss, said, “We at Pluss prioritize all our activities towards delivering healthcare to our customers in the fastest, easiest and most reliable way possible.. With the help of this funding, we will expand our presence across 5 cities by the end of this year.”, as reported by nextbigwhat.com.

Pluss CEO Atit Jain further states that We at Pluss prioritize all our activities towards delivering healthcare to our customers in the fastest, easiest and most reliable way possible, as confirmed by techportal.in.

By the end of this year it plans to add a lot more to its product categories, including Medical Tests and Surgical Equipment. With the health products market expected to grow at a CAGR of 15% and touch $158.2 Billion in 2017, Pluss has placed a bet on hyper local delivery, envisioning emerging as India's reigning name in the healthcare sector, according to Businessstandard.

 
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News